Picture of Biocartis NV logo

BCART Biocartis NV Cashflow Statement

0.000.00%
be flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for Biocartis NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-42-48.2-64.1-62.9-71.5
Depreciation
Non-Cash Items-1.03610.117.812
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-3.51-4.11-9.96-3.85-16.1
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-41.4-42-54.3-39.3-65.7
Capital Expenditures-4.32-5.83-2.52-3.02-3.75
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.0020.008-2.98-0.9870.007
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-4.32-5.82-5.5-4.01-3.75
Financing Cash Flow Items-0.038-0.029-0.037-0.05-0.115
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities75.3-1.51175-11.5-1.2
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash29.5-49.2115-55.1-70.1

Or unlock with your email

Or unlock with your email